LifeArc launched bold new strategy for their Childhood Cancer Translational Challenge

Marc Ramis Castelltort, Managing Partner at Montana Impact Fund, shared a post by LifeArc on LinkedIn, adding:

“A very special atmosphere yesterday in London at the presentation of the Childhood Cancer Translation Challenge.

It is the leading cause of disease-related death in children over 5 globally. Also, 95% Childhood Cancer survivors have significant health issues by 45 years old.

This amazing initiative aims to bridge the gaps in childhood cancer translational research.”

Quoting LifeArc‘s post:

“We believe we can do better for children with cancer. Yesterday, we officially launched our bold new strategy for our Childhood Cancer Translational Challenge.

Our aim is to catalyse a paradigm shift in how we understand, diagnose and treat childhood cancers. To do this, we are focussing on 3 key priorities:

1.Better treatments: Developing therapies specifically targeted to the unique biology of childhood cancers.

2.Better trials: Improving the way clinical trials are run to help make sure the most promising new treatments get to the children who need them more quickly.

3.Better decisions: Using advanced biomarkers to guide clinicians to make informed decisions at diagnosis and throughout treatment.

Read more.”

Source: Marc Ramis Castelltort/LinkedIn and LifeArc/LinkedIn